ANXA1 promotes intrahepatic cholangiocarcinoma proliferation and growth by regulating glutamine metabolism through GOT1 stabilization
Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor with a poor prognosis, marked by a postoperative recurrence rate of 50–60% and a 5-year survival rate of 8–30%. Abnormal tumor metabolism, particularly, amino acid metabolism, plays a key role in malignant progression. Ho...
Saved in:
| Main Authors: | Yanyu Gong, Liwen Chen, Hao Wang, Dijie Zheng, Futang Li, Changhao Wu, Yongning Li, Yazhu Deng, Zhiwei He, Chao Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03400-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GOT2: New therapeutic target in pancreatic cancer
by: Jiarui Bu, et al.
Published: (2025-07-01) -
Comprehensive analysis and experiments identified ANXA1 as an unfavorable prognosticator in glioma
by: Yu Fan, et al.
Published: (2025-03-01) -
A Pilot Study of ANXA2, MED12, CALM1 and MAPK1 Gene Variants in Primary Hyperparathyroidism
by: Chorti A, et al.
Published: (2025-03-01) -
Glioma promotes macrophage immunosuppressive phenotype through ANXA1 in a methionine metabolism-dependent manner
by: Hong Hu, et al.
Published: (2025-07-01) -
EtSERPIN1 binding with chicken ANXA2 is essential for Eimeria tenella attachment and invasion process
by: Zengbao Wang, et al.
Published: (2025-07-01)